| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 3.64e-06 | 145 | 213 | 10 | GO:0004713 | |
| GeneOntologyMolecularFunction | protein kinase activity | EPHB2 EPHB4 TRIO SPEG CDK14 PTK6 RPS6KC1 JAK1 CSNK1A1L PIK3C3 RPS6KL1 BAZ1B RET ZAP70 GUCY2C CSNK1A1 IRAK4 HCK EPHA4 EPHA5 | 7.18e-06 | 600 | 213 | 20 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHB2 EPHB4 TRIO SPEG CDK14 PTK6 RPS6KC1 JAK1 CSNK1A1L PIK3C3 RPS6KL1 IPPK BAZ1B RET ZAP70 GUCY2C CSNK1A1 IRAK4 HCK EPHA4 EPHA5 | 2.48e-05 | 709 | 213 | 21 | GO:0016773 |
| GeneOntologyMolecularFunction | ephrin receptor activity | 4.30e-05 | 19 | 213 | 4 | GO:0005003 | |
| GeneOntologyMolecularFunction | kinase activity | EPHB2 EPHB4 TRIO SPEG CDK14 PTK6 RPS6KC1 JAK1 CSNK1A1L PIK3C3 RPS6KL1 IPPK BAZ1B RET ZAP70 GUCY2C CSNK1A1 IRAK4 HCK EPHA4 EPHA5 | 7.28e-05 | 764 | 213 | 21 | GO:0016301 |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 1.27e-04 | 46 | 213 | 5 | GO:0004715 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.76e-04 | 118 | 213 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB2 EPHB4 CDS1 TRIO SPEG CDK14 PTK6 RPS6KC1 JAK1 CSNK1A1L PIK3C3 RPS6KL1 IPPK BAZ1B RET ZAP70 GUCY2C CSNK1A1 IRAK4 HCK EPHA4 EPHA5 | 4.59e-04 | 938 | 213 | 22 | GO:0016772 |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 4.95e-04 | 15 | 213 | 3 | GO:0005005 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | ARHGAP32 SNX21 CLVS1 SNX19 RPS6KC1 AP2A2 SNX6 SNX8 SNX27 SNX15 ESYT3 | 6.10e-04 | 316 | 213 | 11 | GO:0035091 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 6.47e-04 | 65 | 213 | 5 | GO:0004714 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 6.70e-04 | 4 | 213 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | A-type (transient outward) potassium channel activity | 6.70e-04 | 4 | 213 | 2 | GO:0005250 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 6.99e-04 | 38 | 213 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | phospholipid binding | ARHGAP32 ATP8B1 SNX21 CLVS1 SNX19 RPS6KC1 NF1 AP2A2 SNX6 SNX8 SNX27 SNX15 PLTP SPTBN4 ESYT3 | 8.33e-04 | 548 | 213 | 15 | GO:0005543 |
| GeneOntologyMolecularFunction | calmodulin binding | 8.41e-04 | 230 | 213 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | phosphatidylethanolamine binding | 1.02e-03 | 19 | 213 | 3 | GO:0008429 | |
| GeneOntologyCellularComponent | endosome | ARHGAP32 TRIO SNX21 ACE CLVS1 SNX19 RPS6KC1 GH1 JAK1 AP2A1 AP2A2 SNX6 PIK3C3 SNX8 DIAPH2 SNX27 CCR3 GPC1 SIAH1 SCAMP2 RET MON1B TBC1D17 TAB3 FURIN ATP6V0A4 IRAK4 HTT EPHA4 | 6.76e-06 | 1167 | 211 | 29 | GO:0005768 |
| GeneOntologyCellularComponent | TRC complex | 1.01e-04 | 2 | 211 | 2 | GO:0072380 | |
| GeneOntologyCellularComponent | beta-catenin destruction complex | 2.69e-04 | 13 | 211 | 3 | GO:0030877 | |
| GeneOntologyCellularComponent | myosin complex | 3.21e-04 | 59 | 211 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | endosome membrane | ARHGAP32 SNX21 CLVS1 SNX19 AP2A1 AP2A2 SNX6 SNX8 SNX27 SCAMP2 RET TAB3 FURIN ATP6V0A4 IRAK4 EPHA4 | 4.26e-04 | 602 | 211 | 16 | GO:0010008 |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 5.99e-04 | 185 | 211 | 8 | GO:0009898 | |
| Domain | PX | 7.04e-08 | 49 | 211 | 8 | PF00787 | |
| Domain | PX | 8.30e-08 | 50 | 211 | 8 | PS50195 | |
| Domain | - | 9.75e-08 | 51 | 211 | 8 | 3.30.1520.10 | |
| Domain | Phox | 1.14e-07 | 52 | 211 | 8 | IPR001683 | |
| Domain | Pkinase_Tyr | EPHB2 EPHB4 PTK6 JAK1 RET ZAP70 GUCY2C IRAK4 HCK EPHA4 EPHA5 | 2.45e-07 | 129 | 211 | 11 | PF07714 |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | EPHB2 EPHB4 PTK6 JAK1 RET ZAP70 GUCY2C IRAK4 HCK EPHA4 EPHA5 | 4.84e-07 | 138 | 211 | 11 | IPR001245 |
| Domain | Tyr_kinase_cat_dom | 6.67e-07 | 88 | 211 | 9 | IPR020635 | |
| Domain | TyrKc | 6.67e-07 | 88 | 211 | 9 | SM00219 | |
| Domain | PROTEIN_KINASE_TYR | 1.53e-06 | 97 | 211 | 9 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.53e-06 | 97 | 211 | 9 | IPR008266 | |
| Domain | Myosin-like_IQ_dom | 1.79e-06 | 19 | 211 | 5 | IPR027401 | |
| Domain | - | 1.79e-06 | 19 | 211 | 5 | 4.10.270.10 | |
| Domain | IQ | 3.69e-06 | 81 | 211 | 8 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 8.14e-06 | 90 | 211 | 8 | IPR000048 | |
| Domain | PX | 9.55e-06 | 44 | 211 | 6 | SM00312 | |
| Domain | IQ | 1.04e-05 | 93 | 211 | 8 | PS50096 | |
| Domain | Prot_kinase_dom | EPHB2 EPHB4 TRIO SPEG CDK14 PTK6 RPS6KC1 JAK1 CSNK1A1L RPS6KL1 RET ZAP70 GUCY2C CSNK1A1 IRAK4 HCK EPHA4 EPHA5 | 1.19e-05 | 489 | 211 | 18 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | EPHB2 EPHB4 TRIO SPEG CDK14 PTK6 RPS6KC1 JAK1 CSNK1A1L RPS6KL1 RET ZAP70 GUCY2C CSNK1A1 IRAK4 HCK EPHA4 EPHA5 | 1.32e-05 | 493 | 211 | 18 | PS50011 |
| Domain | Kinase-like_dom | EPHB2 EPHB4 TRIO SPEG CDK14 PTK6 RPS6KC1 JAK1 CSNK1A1L PIK3C3 RPS6KL1 RET ZAP70 GUCY2C CSNK1A1 IRAK4 HCK EPHA4 EPHA5 | 1.34e-05 | 542 | 211 | 19 | IPR011009 |
| Domain | RECEPTOR_TYR_KIN_V_2 | 1.45e-05 | 14 | 211 | 4 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 1.45e-05 | 14 | 211 | 4 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 1.45e-05 | 14 | 211 | 4 | IPR001426 | |
| Domain | EphA2_TM | 1.45e-05 | 14 | 211 | 4 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 1.45e-05 | 14 | 211 | 4 | IPR001090 | |
| Domain | Eph_TM | 1.45e-05 | 14 | 211 | 4 | IPR027936 | |
| Domain | EPH_lbd | 1.45e-05 | 14 | 211 | 4 | SM00615 | |
| Domain | Ephrin_lbd | 1.45e-05 | 14 | 211 | 4 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 1.45e-05 | 14 | 211 | 4 | IPR016257 | |
| Domain | EPH_LBD | 1.45e-05 | 14 | 211 | 4 | PS51550 | |
| Domain | IQ | 1.53e-05 | 71 | 211 | 7 | PF00612 | |
| Domain | PROTEIN_KINASE_ATP | EPHB2 EPHB4 TRIO SPEG CDK14 PTK6 RPS6KC1 JAK1 CSNK1A1L RPS6KL1 RET ZAP70 CSNK1A1 IRAK4 HCK EPHA4 EPHA5 | 1.93e-05 | 459 | 211 | 17 | PS00107 |
| Domain | Myosin_head_motor_dom | 6.50e-05 | 38 | 211 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 6.50e-05 | 38 | 211 | 5 | PS51456 | |
| Domain | Myosin_head | 6.50e-05 | 38 | 211 | 5 | PF00063 | |
| Domain | MYSc | 6.50e-05 | 38 | 211 | 5 | SM00242 | |
| Domain | SGTA_dimer | 1.27e-04 | 2 | 211 | 2 | IPR032374 | |
| Domain | - | 1.27e-04 | 2 | 211 | 2 | 2.60.40.1030 | |
| Domain | SGTA_dimer | 1.27e-04 | 2 | 211 | 2 | PF16546 | |
| Domain | Clathrin_a-adaptin_app_Ig-like | 1.27e-04 | 2 | 211 | 2 | IPR013038 | |
| Domain | AP2_complex_asu | 1.27e-04 | 2 | 211 | 2 | IPR017104 | |
| Domain | Clathrin_a-adaptin_app_sub_C | 1.27e-04 | 2 | 211 | 2 | IPR003164 | |
| Domain | UPF0028 | 1.27e-04 | 2 | 211 | 2 | PS01237 | |
| Domain | Alpha_adaptin_C | 1.27e-04 | 2 | 211 | 2 | PF02296 | |
| Domain | MIT | 1.61e-04 | 10 | 211 | 3 | SM00745 | |
| Domain | MIT | 1.61e-04 | 10 | 211 | 3 | PF04212 | |
| Domain | Ephrin_rec_like | 1.66e-04 | 25 | 211 | 4 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.66e-04 | 25 | 211 | 4 | IPR011641 | |
| Domain | - | 1.76e-04 | 73 | 211 | 6 | 2.60.120.260 | |
| Domain | BTB | 2.13e-04 | 180 | 211 | 9 | SM00225 | |
| Domain | HECT | 2.27e-04 | 27 | 211 | 4 | PF00632 | |
| Domain | HECTc | 2.27e-04 | 27 | 211 | 4 | SM00119 | |
| Domain | HECT_dom | 2.27e-04 | 27 | 211 | 4 | IPR000569 | |
| Domain | HECT | 2.27e-04 | 27 | 211 | 4 | PS50237 | |
| Domain | BTB/POZ_dom | 2.61e-04 | 185 | 211 | 9 | IPR000210 | |
| Domain | - | 3.74e-04 | 13 | 211 | 3 | 1.20.58.280 | |
| Domain | Shal-type_N | 3.78e-04 | 3 | 211 | 2 | IPR021645 | |
| Domain | RFX1_trans_act | 3.78e-04 | 3 | 211 | 2 | IPR007668 | |
| Domain | Ryanodine_rcpt | 3.78e-04 | 3 | 211 | 2 | IPR003032 | |
| Domain | K_chnl_volt-dep_Kv4_C | 3.78e-04 | 3 | 211 | 2 | IPR024587 | |
| Domain | RFX1_trans_act | 3.78e-04 | 3 | 211 | 2 | PF04589 | |
| Domain | DUF3399 | 3.78e-04 | 3 | 211 | 2 | PF11879 | |
| Domain | K_chnl_volt-dep_Kv4 | 3.78e-04 | 3 | 211 | 2 | IPR003975 | |
| Domain | Shal-type | 3.78e-04 | 3 | 211 | 2 | PF11601 | |
| Domain | Ryanrecept_TM4-6 | 3.78e-04 | 3 | 211 | 2 | IPR009460 | |
| Domain | RyR | 3.78e-04 | 3 | 211 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 3.78e-04 | 3 | 211 | 2 | PF06459 | |
| Domain | Ryan_recept | 3.78e-04 | 3 | 211 | 2 | IPR013333 | |
| Domain | Protein_kinase_ATP_BS | EPHB2 EPHB4 SPEG CDK14 PTK6 JAK1 CSNK1A1L RET ZAP70 CSNK1A1 HCK EPHA4 EPHA5 | 3.93e-04 | 379 | 211 | 13 | IPR017441 |
| Domain | MIT | 4.72e-04 | 14 | 211 | 3 | IPR007330 | |
| Domain | ARM-type_fold | TOGARAM1 RYR3 NF1 AP2A1 AP2A2 PIK3C3 XPO6 ASPM DIAPH2 CTNNBL1 CFAP69 HTT | 4.96e-04 | 339 | 211 | 12 | IPR016024 |
| Domain | VG_K_chnl | 5.01e-04 | 33 | 211 | 4 | IPR028325 | |
| Domain | Myosin_N | 5.85e-04 | 15 | 211 | 3 | PF02736 | |
| Domain | Myosin_N | 5.85e-04 | 15 | 211 | 3 | IPR004009 | |
| Domain | Galactose-bd-like | 6.90e-04 | 94 | 211 | 6 | IPR008979 | |
| Domain | Clathrin_a/coatomer_app_sub_C | 7.51e-04 | 4 | 211 | 2 | IPR015873 | |
| Domain | - | 7.51e-04 | 4 | 211 | 2 | 3.30.310.30 | |
| Domain | LRRNT | 8.60e-04 | 98 | 211 | 6 | IPR000372 | |
| Domain | LRRNT | 8.60e-04 | 98 | 211 | 6 | SM00013 | |
| Domain | - | 9.76e-04 | 222 | 211 | 9 | 1.25.10.10 | |
| Domain | ARM-like | 1.03e-03 | 270 | 211 | 10 | IPR011989 | |
| Domain | Myosin_S1_N | 1.24e-03 | 5 | 211 | 2 | IPR008989 | |
| Domain | SKP1/BTB/POZ | 1.41e-03 | 189 | 211 | 8 | IPR011333 | |
| Domain | SH2 | 1.56e-03 | 110 | 211 | 6 | SM00252 | |
| Domain | SH2 | 1.64e-03 | 111 | 211 | 6 | PS50001 | |
| Domain | SH2 | 1.72e-03 | 112 | 211 | 6 | IPR000980 | |
| Domain | - | 1.72e-03 | 112 | 211 | 6 | 3.30.505.10 | |
| Domain | RIH_assoc-dom | 1.85e-03 | 6 | 211 | 2 | IPR013662 | |
| Domain | ADEAMc | 1.85e-03 | 6 | 211 | 2 | SM00552 | |
| Domain | A_deamin | 1.85e-03 | 6 | 211 | 2 | PF02137 | |
| Domain | A_DEAMIN_EDITASE | 1.85e-03 | 6 | 211 | 2 | PS50141 | |
| Domain | Ins145_P3_rec | 1.85e-03 | 6 | 211 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.85e-03 | 6 | 211 | 2 | PF08454 | |
| Domain | RIH_dom | 1.85e-03 | 6 | 211 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.85e-03 | 6 | 211 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.85e-03 | 6 | 211 | 2 | IPR015925 | |
| Domain | - | 1.85e-03 | 6 | 211 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.85e-03 | 6 | 211 | 2 | PF01365 | |
| Domain | A_deamin | 1.85e-03 | 6 | 211 | 2 | IPR002466 | |
| Domain | Ion_trans_dom | 1.88e-03 | 114 | 211 | 6 | IPR005821 | |
| Domain | Ion_trans | 1.88e-03 | 114 | 211 | 6 | PF00520 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 4.40e-06 | 92 | 144 | 8 | M27201 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 1.26e-05 | 51 | 144 | 6 | M27311 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_AUTOPHAGY_VESICLE_NUCLEATION | 2.04e-05 | 6 | 144 | 3 | M47681 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | EPHB2 EPHB4 MYH11 TRIO SPTAN1 NAB1 AP2A1 AP2A2 FLRT3 GPC1 SIAH1 RET SPTBN4 MYH14 SMARCA4 EPHA4 EPHA5 | 7.95e-05 | 575 | 144 | 17 | M29853 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 ANKS6 LRRC24 TRIO MYO7A SPEG JADE1 RYR1 MDN1 PNPLA6 AP2A1 SH3TC1 XPO6 KLHL21 SNX8 DIAPH2 SNX15 ZNF579 HERC2 ARSJ AMBRA1 ZNF865 FAAP100 TBC1D17 ADAMTS7 FURIN HELZ2 UBE3C ADAT1 HTT | 1.21e-11 | 1105 | 215 | 30 | 35748872 |
| Pubmed | 2.47e-09 | 83 | 215 | 9 | 11114734 | ||
| Pubmed | 1.75e-07 | 9 | 215 | 4 | 11403717 | ||
| Pubmed | 1.75e-07 | 9 | 215 | 4 | 33253166 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDS1 TRIO ATP8B1 CDK14 SUCLA2 TTF1 DNAH14 PTK6 PNPLA6 SH3TC1 KCND3 PIK3C3 SEL1L3 ANKRD12 RPS6KL1 TCHP EPB41L4B SGTA TARS2 SPTBN4 GTF3C1 MYH14 CSNK1A1 UBE3C PNPLA7 CFAP69 HTT | 6.08e-07 | 1489 | 215 | 27 | 28611215 |
| Pubmed | cDNA cloning and tissue distribution of five human EPH-like receptor protein-tyrosine kinases. | 9.28e-07 | 4 | 215 | 3 | 7898931 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KDM3A KDM5C SPTAN1 FAM91A1 DAXX NF1 MDN1 PNPLA6 XPO6 RBM15B ZNF579 THOC1 SGTA PARG BAZ1B GTF3C1 HELZ2 SMARCA4 | 1.80e-06 | 774 | 215 | 18 | 15302935 |
| Pubmed | 2.31e-06 | 5 | 215 | 3 | 8530091 | ||
| Pubmed | c-ret regulates cholinergic properties in mouse sympathetic neurons: evidence from mutant mice. | 2.31e-06 | 5 | 215 | 3 | 15233745 | |
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 3.17e-06 | 17 | 215 | 4 | 12217323 | |
| Pubmed | A large family of endosome-localized proteins related to sorting nexin 1. | 3.17e-06 | 17 | 215 | 4 | 11485546 | |
| Pubmed | 3.17e-06 | 17 | 215 | 4 | 12461558 | ||
| Pubmed | Agrin has a pathological role in the progression of oral cancer. | 4.18e-06 | 197 | 215 | 9 | 29872149 | |
| Pubmed | 5.12e-06 | 19 | 215 | 4 | 18206867 | ||
| Pubmed | Expression of Ephs and ephrins in developing mouse inner ear. | 5.12e-06 | 19 | 215 | 4 | 12684176 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | TTF1 MDN1 AP2A1 PIK3C3 ASPM RBM15B HERC2 THOC1 WRN BAZ1B SIAH1 EXOC5 GTF3C1 TSR1 SMARCA4 UBE3C AQR | 5.76e-06 | 759 | 215 | 17 | 35915203 |
| Pubmed | Multiple roles of EPH receptors and ephrins in neural development. | 6.37e-06 | 20 | 215 | 4 | 11256076 | |
| Pubmed | 6.37e-06 | 20 | 215 | 4 | 10207129 | ||
| Pubmed | 6.37e-06 | 20 | 215 | 4 | 9530499 | ||
| Pubmed | 6.37e-06 | 20 | 215 | 4 | 9576626 | ||
| Pubmed | 7.83e-06 | 21 | 215 | 4 | 9267020 | ||
| Pubmed | 7.83e-06 | 21 | 215 | 4 | 11128993 | ||
| Pubmed | Eph receptors and ephrins: regulators of guidance and assembly. | 7.83e-06 | 21 | 215 | 4 | 10730216 | |
| Pubmed | Eph receptors and ephrins demarcate cerebellar lobules before and during their formation. | 7.83e-06 | 21 | 215 | 4 | 10495276 | |
| Pubmed | Developmental expression of Eph and ephrin family genes in mammalian small intestine. | 7.83e-06 | 21 | 215 | 4 | 20112066 | |
| Pubmed | Ephrin-B2 governs morphogenesis of endolymphatic sac and duct epithelia in the mouse inner ear. | 7.83e-06 | 21 | 215 | 4 | 24583262 | |
| Pubmed | Beta-NAP, a cerebellar degeneration antigen, is a neuron-specific vesicle coat protein. | 8.01e-06 | 7 | 215 | 3 | 7671305 | |
| Pubmed | 8.01e-06 | 7 | 215 | 3 | 17686994 | ||
| Pubmed | Pou3f4-mediated regulation of ephrin-b2 controls temporal bone development in the mouse. | 8.01e-06 | 7 | 215 | 3 | 25299585 | |
| Pubmed | ARHGAP32 MYH11 TRIO MYO7A SPTAN1 TSC1 SUCLA2 CSNK1A1L NF1 PNPLA6 AP2A1 AP2A2 KCND3 SNX27 HRG GPC1 EPB41L4B SPTBN4 MYH14 CSNK1A1 SMARCA4 LRRCC1 EIF3A HCK | 9.96e-06 | 1431 | 215 | 24 | 37142655 | |
| Pubmed | Promotion of proliferation in the developing cerebral cortex by EphA4 forward signaling. | 1.15e-05 | 23 | 215 | 4 | 19542359 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TRIP6 SPTAN1 SRM TSC1 NF1 MDN1 PNPLA6 AP2A1 AP2A2 ASPM SNX27 HERC2 GPC1 BAZ1B AMBRA1 GTF3C1 MYH14 CTNNBL1 SMARCA4 EIF3A NUP93 ZNF281 AQR | 1.25e-05 | 1353 | 215 | 23 | 29467282 |
| Pubmed | LMO7 deficiency reveals the significance of the cuticular plate for hearing function. | 1.28e-05 | 8 | 215 | 3 | 30850599 | |
| Pubmed | Eph receptors and their ephrin ligands are expressed in developing mouse pancreas. | 1.37e-05 | 24 | 215 | 4 | 16446123 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | EPHB2 EPHB4 TRIO CDK14 PTK6 JAK1 CSNK1A1L NF1 AP2A1 AP2A2 SNX27 RET GTF3C1 CSNK1A1 IRAK4 PDE7B HCK EPHA4 | 1.63e-05 | 910 | 215 | 18 | 36736316 |
| Pubmed | 1.90e-05 | 9 | 215 | 3 | 22911456 | ||
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 1.91e-05 | 26 | 215 | 4 | 26949039 | |
| Pubmed | A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. | EPHB4 MYH11 TRIP6 AP2A1 AP2A2 AFM DNAH8 EPB41L4B CSNK1A1 EPHA5 | 2.07e-05 | 302 | 215 | 10 | 30561431 |
| Pubmed | EphB signaling regulates target innervation in the developing and deafferented auditory brainstem. | 2.71e-05 | 10 | 215 | 3 | 22021100 | |
| Pubmed | 2.71e-05 | 10 | 215 | 3 | 25923646 | ||
| Pubmed | EphB2 guides axons at the midline and is necessary for normal vestibular function. | 2.71e-05 | 10 | 215 | 3 | 10839360 | |
| Pubmed | HOXA13 directly regulates EphA6 and EphA7 expression in the genital tubercle vascular endothelia. | 2.71e-05 | 10 | 215 | 3 | 17304517 | |
| Pubmed | 2.80e-05 | 250 | 215 | 9 | 33536335 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRIO SPTAN1 SUCLA2 NF1 MDN1 AP2A1 AP2A2 RBM15B MYO18B THOC1 IRS4 BAZ1B SCAMP2 TARS2 GTF3C1 TSR1 MYH14 CTNNBL1 SMARCA4 EIF3A NUP93 UBE3C AQR | 2.81e-05 | 1425 | 215 | 23 | 30948266 |
| Pubmed | EFCAB5 MYH11 ADAM7 SPTAN1 TSC1 RPS6KC1 RINT1 MDN1 AP2A1 AP2A2 EFCAB12 ASPM DLEC1 DNAH8 IRS4 RARRES1 SPTBN4 GTF3C1 MYH14 TENM1 EIF3A CFAP69 EPHA4 | 3.37e-05 | 1442 | 215 | 23 | 35575683 | |
| Pubmed | ARHGAP32 LRRC24 TRIO SPTAN1 TSC1 CSNK1A1L NF1 MDN1 AP2A1 AP2A2 DIAPH2 HERC2 SPTBN4 ZKSCAN1 CSNK1A1 SMARCA4 LRRC15 EPHA4 | 3.43e-05 | 963 | 215 | 18 | 28671696 | |
| Pubmed | 3.71e-05 | 11 | 215 | 3 | 22171039 | ||
| Pubmed | 3.71e-05 | 11 | 215 | 3 | 18218630 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 27008860 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 23354688 | ||
| Pubmed | Tissue-specific distribution of mouse casein kinase I alpha mRNA. | 3.80e-05 | 2 | 215 | 2 | 9522121 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 9489997 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 11572780 | ||
| Pubmed | Casein Kinase 1α Regulates Testosterone Synthesis and Testis Development in Adult Mice. | 3.80e-05 | 2 | 215 | 2 | 36929849 | |
| Pubmed | Vagus nerve stimulation induces widespread cortical and behavioral activation. | 3.80e-05 | 2 | 215 | 2 | 33740425 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 22234463 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 22374425 | ||
| Pubmed | Cloning of cDNAs encoding two related 100-kD coated vesicle proteins (alpha-adaptins). | 3.80e-05 | 2 | 215 | 2 | 2564002 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 35695793 | ||
| Pubmed | Prodomain of Furin Promotes Phospholipid Transfer Protein Proteasomal Degradation in Hepatocytes. | 3.80e-05 | 2 | 215 | 2 | 29680823 | |
| Pubmed | Exploring the role of casein kinase 1α splice variants across cancer cell lines. | 3.80e-05 | 2 | 215 | 2 | 38852281 | |
| Pubmed | Casein kinase 1 α phosphorylates the Wnt regulator Jade-1 and modulates its activity. | 3.80e-05 | 2 | 215 | 2 | 25100726 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 23690993 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 25986216 | ||
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 3.80e-05 | 2 | 215 | 2 | 17118445 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 32286515 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 37102362 | ||
| Pubmed | GDNF acts as a chemoattractant to support ephrinA-induced repulsion of limb motor axons. | 3.80e-05 | 2 | 215 | 2 | 21109439 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 24361808 | ||
| Pubmed | Pre-synaptic and post-synaptic localization of EphA4 and EphB2 in adult mouse forebrain. | 3.80e-05 | 2 | 215 | 2 | 18410519 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 18086666 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 30293567 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 12565913 | ||
| Pubmed | Drosophila glucome screening identifies Ck1alpha as a regulator of mammalian glucose metabolism. | 3.80e-05 | 2 | 215 | 2 | 25994086 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 9192302 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 34360793 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 7556644 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 14671660 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 17496728 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 28077917 | ||
| Pubmed | Divergent Roles of Ephrin-B2/EphB4 Guidance System in Pulmonary Hypertension. | 3.80e-05 | 2 | 215 | 2 | 36519465 | |
| Pubmed | The roles of Eph receptors in contextual fear conditioning memory formation. | 3.80e-05 | 2 | 215 | 2 | 26165136 | |
| Pubmed | Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. | 3.80e-05 | 2 | 215 | 2 | 19366806 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 12878599 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 15700541 | ||
| Pubmed | Cloning, physical mapping and structural characterization of the human alpha(A)-adaptin gene. | 3.80e-05 | 2 | 215 | 2 | 12036598 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 26912788 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 35809272 | ||
| Pubmed | Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. | 3.80e-05 | 2 | 215 | 2 | 12640454 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 23054685 | ||
| Pubmed | Mouse germ cell-less as an essential component for nuclear integrity. | 3.80e-05 | 2 | 215 | 2 | 12556490 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 36914640 | ||
| Pubmed | CSNK1A1/CK1α suppresses autoimmunity by restraining the CGAS-STING1 signaling. | 3.80e-05 | 2 | 215 | 2 | 37723657 | |
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 3.80e-05 | 2 | 215 | 2 | 12640042 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 18695888 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 14592949 | ||
| Pubmed | KSHV enhances mesenchymal stem cell homing and promotes KS-like pathogenesis. | 3.80e-05 | 2 | 215 | 2 | 32777727 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 16840724 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 9799464 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 10448096 | ||
| Interaction | ZCCHC10 interactions | ESR2 DAXX TAF8 AP2A1 AP2A2 ASPM HERC2 EPB41L4B SIAH1 GTF3C1 CTNNBL1 AQR | 8.03e-06 | 236 | 212 | 12 | int:ZCCHC10 |
| Interaction | TACSTD2 interactions | 9.17e-06 | 129 | 212 | 9 | int:TACSTD2 | |
| Interaction | PRB4 interactions | 1.13e-05 | 5 | 212 | 3 | int:PRB4 | |
| Interaction | TOP3B interactions | EPHB4 ANKS6 LRRC24 TRIO MYO7A SPEG SPTAN1 JADE1 RYR1 MDN1 PNPLA6 AP2A1 SH3TC1 XPO6 KLHL21 SNX8 DIAPH2 SNX15 ZNF579 HERC2 THOC1 ARSJ WRN AMBRA1 ZNF865 FAAP100 TBC1D17 ADAMTS7 CSNK1A1 FURIN HELZ2 UBE3C ADAT1 HTT | 1.14e-05 | 1470 | 212 | 34 | int:TOP3B |
| Interaction | SPRR2D interactions | 1.96e-05 | 16 | 212 | 4 | int:SPRR2D | |
| Interaction | CCL3 interactions | EPHB4 ARHGAP32 LRRC24 METRNL CCR1 CCR3 PLTP ADAMTS2 MON1B LINGO1 | 1.97e-05 | 178 | 212 | 10 | int:CCL3 |
| Interaction | PIK3R2 interactions | EPHB2 ADARB2 STAB1 RINT1 IRS4 RET MMP25 MYH14 HCK EPHA4 EPHA5 | 3.38e-05 | 230 | 212 | 11 | int:PIK3R2 |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 8.28e-08 | 29 | 141 | 6 | 754 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 3.34e-06 | 14 | 141 | 4 | 1095 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.80e-04 | 3 | 141 | 2 | 287 | |
| GeneFamily | Potassium voltage-gated channels | 2.60e-04 | 40 | 141 | 4 | 274 | |
| GeneFamily | Sterile alpha motif domain containing | 6.26e-04 | 88 | 141 | 5 | 760 | |
| GeneFamily | SH2 domain containing | 1.17e-03 | 101 | 141 | 5 | 741 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.24e-03 | 7 | 141 | 2 | 1113 | |
| GeneFamily | Adenosine deaminases acting on RNA | 1.64e-03 | 8 | 141 | 2 | 1303 | |
| GeneFamily | Regulatory factor X family | 1.64e-03 | 8 | 141 | 2 | 1153 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.08e-03 | 115 | 141 | 5 | 769 | |
| GeneFamily | CD molecules|C-C motif chemokine receptors | 2.61e-03 | 10 | 141 | 2 | 1091 | |
| GeneFamily | Patatin like phospholipase domain containing | 2.61e-03 | 10 | 141 | 2 | 466 | |
| GeneFamily | UPF1 like RNA helicases | 3.17e-03 | 11 | 141 | 2 | 1169 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 3.79e-03 | 12 | 141 | 2 | 1290 | |
| GeneFamily | Myosin heavy chains | 5.93e-03 | 15 | 141 | 2 | 1098 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 6.96e-03 | 50 | 141 | 3 | 1293 | |
| GeneFamily | Dyneins, axonemal | 7.61e-03 | 17 | 141 | 2 | 536 | |
| GeneFamily | Fibronectin type III domain containing | 8.41e-03 | 160 | 141 | 5 | 555 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 9.47e-03 | 19 | 141 | 2 | 50 | |
| Coexpression | FIRESTEIN_PROLIFERATION | 1.17e-06 | 166 | 214 | 10 | M5354 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | TTC23L EFCAB12 FAM227A DLEC1 ERICH3 EFCAB6 PLEKHG7 C1orf87 CFAP57 CFAP69 | 2.88e-08 | 189 | 214 | 10 | b679920f0993e917dd86da082113bfbd85ea1ca5 |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | DIAPH2 FAM227A DLEC1 PLTP ERICH3 C1orf87 RFX2 RFX3 CFAP57 CFAP69 | 3.87e-08 | 195 | 214 | 10 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | TTC23L EFCAB12 FAM227A DLEC1 ERICH3 EFCAB6 PLEKHG7 C1orf87 CFAP57 | 2.44e-07 | 181 | 214 | 9 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | TTC23L FAM227A DLEC1 ERICH3 EFCAB6 PLEKHG7 C1orf87 CFAP57 CFAP69 | 3.36e-07 | 188 | 214 | 9 | 34b11f72ca73153d02edcd09b38983ad1a504659 |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | TTC23L EFCAB12 FAM227A DLEC1 ERICH3 EFCAB6 PLEKHG7 C1orf87 CFAP57 | 3.51e-07 | 189 | 214 | 9 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | TTC23L EFCAB12 FAM227A DLEC1 ERICH3 EFCAB6 C1orf87 CFAP57 CFAP69 | 3.51e-07 | 189 | 214 | 9 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-07 | 190 | 214 | 9 | cbba3d94a4c3e0b0d14f3b7c60dba5d6e097c5e3 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 4.19e-07 | 193 | 214 | 9 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | EFCAB12 FAM227A DLEC1 ERICH3 EFCAB6 C1orf87 RFX3 CFAP57 CFAP69 | 4.38e-07 | 194 | 214 | 9 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | EFCAB12 FAM227A DLEC1 ERICH3 EFCAB6 C1orf87 RFX3 CFAP57 CFAP69 | 4.98e-07 | 197 | 214 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | Sigmoid-T_cell-Treg|T_cell / Region, Cell class and subclass | 5.19e-07 | 198 | 214 | 9 | e2d2f9f209f77d0c48cfe3e9902c0ae0795511b2 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.19e-07 | 198 | 214 | 9 | c7dbf24caae5c4ef285845d13055de9e07281bb3 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-SPP1+_Mac|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.42e-07 | 199 | 214 | 9 | c7fc2ac1601346aac71e7620a8a440fde8d92dbd | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | EFCAB12 FAM227A DLEC1 B4GALNT3 ERICH3 EFCAB6 PLEKHG7 C1orf87 CFAP57 | 5.65e-07 | 200 | 214 | 9 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 161 | 214 | 8 | 3f3a2148c8d65e6a06f8d8116a3aa58dda17d618 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.82e-06 | 171 | 214 | 8 | 26b34dc069cc15b75a0c13cb8c5d81e074788160 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.66e-06 | 180 | 214 | 8 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.66e-06 | 180 | 214 | 8 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.66e-06 | 180 | 214 | 8 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 3.26e-06 | 185 | 214 | 8 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.26e-06 | 185 | 214 | 8 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.53e-06 | 187 | 214 | 8 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 3.68e-06 | 188 | 214 | 8 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.68e-06 | 188 | 214 | 8 | cb091912f9b627a78a8793a37df7f1de839f887f | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.68e-06 | 188 | 214 | 8 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.97e-06 | 190 | 214 | 8 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.97e-06 | 190 | 214 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.13e-06 | 191 | 214 | 8 | 6a8b0987e75456a257954288206da0032605ff2a | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Cdh13|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.34e-06 | 136 | 214 | 7 | 1f3000d5f105c87c80f8ae1dd2264bcd7f757a9c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.46e-06 | 193 | 214 | 8 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 4.46e-06 | 193 | 214 | 8 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.63e-06 | 194 | 214 | 8 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.81e-06 | 195 | 214 | 8 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.81e-06 | 195 | 214 | 8 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.00e-06 | 196 | 214 | 8 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.19e-06 | 197 | 214 | 8 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.38e-06 | 198 | 214 | 8 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-06 | 200 | 214 | 8 | 179afc4bee7a2fd85a3b5dadf32544a63807c164 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-06 | 200 | 214 | 8 | ad52b38df5c71f28829b04cd0e6b97f0f9f7610a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-06 | 200 | 214 | 8 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 5.80e-06 | 200 | 214 | 8 | 25f4c051c2e869481f33c22ad54de97efac444ad | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-06 | 200 | 214 | 8 | 4b4df0fe47498310d94448b8a289e58e4f5b5aa8 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-06 | 200 | 214 | 8 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial-Proteoglycan-expressing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 5.80e-06 | 200 | 214 | 8 | da45a85a4667965b24ba824af871157af5b4cd19 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.04e-06 | 143 | 214 | 7 | 5fb5a4ea93e5cce55d427e3b4a50a979504fad3c | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.91e-06 | 149 | 214 | 7 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.81e-06 | 154 | 214 | 7 | 44d4d99b08216c0901e3bc32743fa0a8b85b5149 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-05 | 156 | 214 | 7 | 58b9520fce6e259b36c3d59e82b712f5e7729e3e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-05 | 161 | 214 | 7 | 63f0b97c741b610c450f65fa5764d712bfe09ce8 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-05 | 162 | 214 | 7 | 80619a93c57fe16daf91dc571874ef9ac888953d | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.60e-05 | 166 | 214 | 7 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.60e-05 | 166 | 214 | 7 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Npw|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.79e-05 | 113 | 214 | 6 | 165de4316059222f33d1e51aeff4554037c0b937 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.79e-05 | 169 | 214 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l12-45|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.86e-05 | 170 | 214 | 7 | e028e22ad051c2628248b212b5d28b891e0ee782 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 170 | 214 | 7 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-05 | 173 | 214 | 7 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 2.16e-05 | 174 | 214 | 7 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.33e-05 | 176 | 214 | 7 | 91ad2c34144f72283ca112fd3b3784f2f6259f65 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 2.41e-05 | 177 | 214 | 7 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 177 | 214 | 7 | 32fecefba1a55e1f418c9a055236fa11175c692d | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 177 | 214 | 7 | 1b153fbfe1323dc589de4af73a52149ea5ce6763 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 179 | 214 | 7 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.59e-05 | 179 | 214 | 7 | 906555ce2ca264a0215b120c7ff7c9b411de6a34 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.79e-05 | 181 | 214 | 7 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 2.89e-05 | 182 | 214 | 7 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.89e-05 | 182 | 214 | 7 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.89e-05 | 182 | 214 | 7 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.09e-05 | 184 | 214 | 7 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.09e-05 | 184 | 214 | 7 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 3.20e-05 | 185 | 214 | 7 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.20e-05 | 185 | 214 | 7 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.67e-05 | 189 | 214 | 7 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-05 | 189 | 214 | 7 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.67e-05 | 189 | 214 | 7 | 2aebea7a6c2f83112d7c504b742f2c04b92e459a | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-05 | 189 | 214 | 7 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.67e-05 | 189 | 214 | 7 | b8cbfc47f3f40b6fccd15899d58c87d07b0001aa | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-05 | 191 | 214 | 7 | 8fd6bdc9d2b1c8d364221d7bc68d03921b668ab5 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.92e-05 | 191 | 214 | 7 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-05 | 191 | 214 | 7 | 51f5af610983aa73b9f4ece6f27d281ebff89a04 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.92e-05 | 191 | 214 | 7 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.92e-05 | 191 | 214 | 7 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 4.06e-05 | 192 | 214 | 7 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-05 | 192 | 214 | 7 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-05 | 192 | 214 | 7 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 4.19e-05 | 193 | 214 | 7 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.19e-05 | 193 | 214 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-parabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-05 | 193 | 214 | 7 | 55eab7d2574e9cc2ed8f08e0a7ca7cbf90fb5818 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.19e-05 | 193 | 214 | 7 | 2684fa361baaa9dc7a18a39ed11c0759e78e4418 | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 4.33e-05 | 194 | 214 | 7 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.33e-05 | 194 | 214 | 7 | 58046894446cb250814252a23f60fdd59c114d77 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-05 | 194 | 214 | 7 | a3adcdc8b87332e8beb9bcd70cf36424af10633d | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-05 | 195 | 214 | 7 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.47e-05 | 195 | 214 | 7 | ce8215d503cad3a9bc7d5d2be4adb57408015593 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 4.62e-05 | 196 | 214 | 7 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.77e-05 | 197 | 214 | 7 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.93e-05 | 198 | 214 | 7 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 4.93e-05 | 198 | 214 | 7 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.09e-05 | 199 | 214 | 7 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.09e-05 | 199 | 214 | 7 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| Drug | ponatinib | 2.27e-07 | 68 | 212 | 8 | ctd:C545373 | |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | EPHB2 ARHGAP32 TRIO KDM5C PTK6 NF1 HERC6 AMBRA1 TBC1D8 IRAK4 NIPAL2 | 2.80e-06 | 199 | 212 | 11 | 5535_DN |
| Drug | VX-745 | 3.05e-06 | 25 | 212 | 5 | CID003038525 | |
| Drug | CI-1033 | 9.68e-06 | 53 | 212 | 6 | CID000156413 | |
| Disease | Colorectal Carcinoma | ESR2 ZNF232 ADARB2 CSNK1A1L NF1 SH3TC1 KCND3 SNX8 DNAH8 IRS4 WRN RET CHST8 GMCL2 GUCY2C TENM1 | 4.22e-05 | 702 | 208 | 16 | C0009402 |
| Disease | Ovarian Mucinous Adenocarcinoma | 6.50e-05 | 31 | 208 | 4 | C1335167 | |
| Disease | Malignant neoplasm of breast | EPHB4 KDM3A CDS1 XIRP1 ESR2 SPTAN1 ATP8B1 APOBEC3A NF1 HRG DLEC1 HERC2 GPC1 C1orf87 RFX2 PLEKHD1 HEY1 TENM1 LONRF3 ZNF281 | 7.99e-05 | 1074 | 208 | 20 | C0006142 |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.48e-04 | 3 | 208 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.48e-04 | 3 | 208 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Familial medullary thyroid carcinoma | 1.48e-04 | 3 | 208 | 2 | C1833921 | |
| Disease | Pheochromocytoma, Extra-Adrenal | 1.81e-04 | 16 | 208 | 3 | C1257877 | |
| Disease | Hodgkins lymphoma | 2.91e-04 | 82 | 208 | 5 | EFO_0000183 | |
| Disease | Myopathy, Centronuclear, Autosomal Recessive | 2.94e-04 | 4 | 208 | 2 | C0410204 | |
| Disease | Manic mood | 2.94e-04 | 4 | 208 | 2 | C0564408 | |
| Disease | Pheochromocytoma | 3.08e-04 | 19 | 208 | 3 | C0031511 | |
| Disease | Congenital absence of kidneys syndrome | 4.88e-04 | 5 | 208 | 2 | C1609433 | |
| Disease | response to bevacizumab, Proteinuria | 4.88e-04 | 5 | 208 | 2 | EFO_0005943, HP_0000093 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.88e-04 | 195 | 208 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | Metastatic melanoma | 5.76e-04 | 54 | 208 | 4 | C0278883 | |
| Disease | Cerebral Astrocytoma | 7.08e-04 | 25 | 208 | 3 | C0750935 | |
| Disease | Intracranial Astrocytoma | 7.08e-04 | 25 | 208 | 3 | C0750936 | |
| Disease | Cardiac Arrhythmia | 7.08e-04 | 25 | 208 | 3 | C0003811 | |
| Disease | Astrocytoma | 7.08e-04 | 25 | 208 | 3 | C0004114 | |
| Disease | Grade I Astrocytoma | 7.08e-04 | 25 | 208 | 3 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 7.08e-04 | 25 | 208 | 3 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 7.08e-04 | 25 | 208 | 3 | C0547065 | |
| Disease | Pilocytic Astrocytoma | 7.08e-04 | 25 | 208 | 3 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 7.08e-04 | 25 | 208 | 3 | C0280783 | |
| Disease | Diffuse Astrocytoma | 7.08e-04 | 25 | 208 | 3 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 7.08e-04 | 25 | 208 | 3 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 7.96e-04 | 26 | 208 | 3 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 7.96e-04 | 26 | 208 | 3 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 7.96e-04 | 26 | 208 | 3 | C0334582 | |
| Disease | Anaplastic astrocytoma | 8.91e-04 | 27 | 208 | 3 | C0334579 | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 1.01e-03 | 7 | 208 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | leucine-rich repeat-containing protein 15 measurement | 1.01e-03 | 7 | 208 | 2 | EFO_0801761 | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 1.10e-03 | 29 | 208 | 3 | cv:C5779548 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.35e-03 | 8 | 208 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | blindness (implicated_via_orthology) | 1.35e-03 | 8 | 208 | 2 | DOID:1432 (implicated_via_orthology) | |
| Disease | sensorineural hearing loss (is_implicated_in) | 1.61e-03 | 33 | 208 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | hemangiopericytoma (is_marker_for) | 1.72e-03 | 9 | 208 | 2 | DOID:264 (is_marker_for) | |
| Disease | angiotensin-converting enzyme measurement | 1.72e-03 | 9 | 208 | 2 | EFO_0006515 | |
| Disease | glaucoma (is_implicated_in) | 2.14e-03 | 10 | 208 | 2 | DOID:1686 (is_implicated_in) | |
| Disease | Malignant Neoplasms | 2.18e-03 | 128 | 208 | 5 | C0006826 | |
| Disease | ovary epithelial cancer (is_implicated_in) | 2.61e-03 | 11 | 208 | 2 | DOID:2152 (is_implicated_in) | |
| Disease | diffuse scleroderma (is_implicated_in) | 2.61e-03 | 11 | 208 | 2 | DOID:1580 (is_implicated_in) | |
| Disease | Paranoia | 2.61e-03 | 11 | 208 | 2 | C1456784 | |
| Disease | receptor-interacting serine/threonine-protein kinase 2 measurement | 2.61e-03 | 11 | 208 | 2 | EFO_0802997 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 3.04e-03 | 200 | 208 | 6 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | beta wave measurement | 3.12e-03 | 12 | 208 | 2 | EFO_0006871 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 3.30e-03 | 346 | 208 | 8 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | response to hydrochlorothiazide, fasting blood glucose measurement | 4.19e-03 | 46 | 208 | 3 | EFO_0004465, EFO_0005202 | |
| Disease | anemia (is_implicated_in) | 4.26e-03 | 14 | 208 | 2 | DOID:2355 (is_implicated_in) | |
| Disease | Sarcoma, Spindle Cell | 4.26e-03 | 14 | 208 | 2 | C0205945 | |
| Disease | extrinsic allergic alveolitis (is_marker_for) | 4.26e-03 | 14 | 208 | 2 | DOID:841 (is_marker_for) | |
| Disease | Sarcoma, Epithelioid | 4.26e-03 | 14 | 208 | 2 | C0205944 | |
| Disease | systemic lupus erythematosus (is_marker_for) | 4.46e-03 | 47 | 208 | 3 | DOID:9074 (is_marker_for) | |
| Disease | Depressive disorder | 4.58e-03 | 289 | 208 | 7 | C0011581 | |
| Disease | smoking status measurement, carotid artery intima media thickness | 4.73e-03 | 48 | 208 | 3 | EFO_0006527, EFO_0007117 | |
| Disease | glucose homeostasis measurement, glucose effectiveness measurement | 4.89e-03 | 15 | 208 | 2 | EFO_0006833, EFO_0006896 | |
| Disease | African Burkitt's lymphoma | 4.89e-03 | 15 | 208 | 2 | C0343640 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 4.89e-03 | 15 | 208 | 2 | C3645536 | |
| Disease | Burkitt Leukemia | 4.89e-03 | 15 | 208 | 2 | C4721444 | |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 5.01e-03 | 49 | 208 | 3 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 | |
| Disease | aspartate aminotransferase measurement | MYO7A SRM ATP8B1 NF1 SH3TC1 SNX8 HRG CCR3 BANK1 PLEKHG7 ZAP70 TBC1D8 ARHGAP45 PDE7B | 5.09e-03 | 904 | 208 | 14 | EFO_0004736 |
| Disease | 5-oxoproline measurement | 5.56e-03 | 16 | 208 | 2 | EFO_0010988 | |
| Disease | Pre-Eclampsia | 5.56e-03 | 16 | 208 | 2 | C0032914 | |
| Disease | methylcobalamin deficiency type cblE, brain serotonin transporter measurement | 5.56e-03 | 16 | 208 | 2 | EFO_0004569, MONDO_0009354 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 5.56e-03 | 16 | 208 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | brain ischemia (biomarker_via_orthology) | 5.95e-03 | 102 | 208 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 6.27e-03 | 17 | 208 | 2 | OBA_2045173 | |
| Disease | ceramide measurement | 6.61e-03 | 235 | 208 | 6 | EFO_0010222 | |
| Disease | Carcinoma of bladder | 7.02e-03 | 18 | 208 | 2 | C0699885 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NLKRRYSFRLHIGRN | 581 | Q15361 | |
| RLRLAELNAQYRARF | 101 | A6NGE7 | |
| AILLYRLENFSFRHL | 56 | Q8NDB2 | |
| LFDRIAQHYALLLFR | 216 | F5H4B4 | |
| VYLRAFHSAVAQRLQ | 311 | Q17RC7 | |
| LAGYFNNTRIRRHLL | 21 | Q5RHP9 | |
| LQHFRSRTIYRNLNP | 341 | A0FGR9 | |
| LDFGYFVRHLRNDRN | 346 | Q9Y6F7 | |
| NYFAHLRLEVLQLTR | 206 | Q5SQH8 | |
| QREEQLQFLIRYHRF | 171 | Q92903 | |
| HREQREYLDQLNALR | 1271 | A6NC98 | |
| FYLRRLDAGLFVLQH | 481 | Q8WYA6 | |
| RLINSINHYDLFIER | 136 | Q9BXI3 | |
| YLNLHAFVRRALHRR | 251 | P12821 | |
| LQRYQGLRFVHLSFV | 361 | Q6L9W6 | |
| ESLLNHFLYEVARRN | 156 | P43652 | |
| VLHLLRSREFLGSNY | 71 | Q9H2U9 | |
| ENTHVRLRIFAARIY | 116 | P31941 | |
| YNEAFNALRRALRHD | 81 | Q7RTU4 | |
| EIVRYFIRHNALRAG | 251 | Q9UIG0 | |
| YVHRDLAARNILINS | 796 | P54756 | |
| RDSNYLRLLFLSRNH | 151 | Q9NZU0 | |
| FLAHADLQRRNSEYL | 441 | A6NE02 | |
| QFLQHRETNLRYLAL | 336 | O95782 | |
| TLHDYLLRNFNLFRL | 461 | O60306 | |
| FLFQLLRGLSYIHQR | 236 | O94921 | |
| FYRRLQSLRQEAINH | 716 | Q8IYM0 | |
| RHELQCDLRRFFLEY | 496 | Q9C0C7 | |
| EVLRVHYRAARTLAN | 1931 | Q6UB98 | |
| AHLGALLARYIQQAR | 56 | P06307 | |
| YELDFRIHLRNEFLR | 341 | O60879 | |
| AQYRLERGQARRLLH | 1101 | Q8IWY9 | |
| GIRLQERRHLDLIYN | 321 | Q9UER7 | |
| RELIDSARRHNFLVY | 381 | Q6NXP0 | |
| YLRQRHSAVILQAAF | 2381 | Q8IZT6 | |
| FAQFRYLQRLLLVHG | 926 | O43520 | |
| YNVTVFGRDLHLRLR | 111 | O95450 | |
| YRGRELRFNLTANQH | 86 | Q9UKP4 | |
| ARRLIHNYNLIYNLS | 501 | Q8N0U7 | |
| SHAEVIARRSFQRYL | 86 | Q9BUB4 | |
| IARRSFQRYLLHQLQ | 91 | Q9BUB4 | |
| FLQHRETNLRYLALE | 336 | O94973 | |
| FRHLRLQYIISDLAS | 331 | Q96IK5 | |
| RASLSRLHRVAQYAR | 291 | Q9UF12 | |
| AQYARAQHVRLLVDA | 301 | Q9UF12 | |
| LRLHYRRALRNNTDP | 371 | Q8N1F7 | |
| SRLRYLIHRTAENFD | 46 | Q9Y3T6 | |
| TFQGLERLQSLHLYR | 126 | Q86UN3 | |
| ARQHALARQLLLYDR | 196 | Q8NDT2 | |
| FSRLLRDHNLTREQF | 11 | Q96P65 | |
| RDHNLTREQFIALYR | 16 | Q96P65 | |
| VARRAFLHFLYTQLE | 436 | Q9NS39 | |
| RRLQLYSRNLEHLVE | 766 | P25092 | |
| SRQYVHRDLAARNVL | 996 | P23458 | |
| PNLTRLQTYRFAEHR | 116 | Q9H8X2 | |
| VARIFAHKQNYDLRR | 206 | Q7L1V2 | |
| QAAYARHRDGRILLF | 371 | Q9NPA2 | |
| VRLQRVTFLALHNYL | 321 | Q8IY17 | |
| GLLEELRDFHRRYNQ | 251 | Q9H3H1 | |
| FSRIYHQNQRADKRR | 411 | Q9NSA2 | |
| FSRIYHQNQRADKRR | 406 | Q9UK17 | |
| FYRSLARHARLNAAL | 4196 | Q9NU22 | |
| ENRASLQYLLRHLRR | 901 | Q92619 | |
| YLFQLLRIADAHLDR | 46 | P04196 | |
| YRLVRRQRSADEQLH | 226 | Q92731 | |
| FRYILNFLRTSHLDL | 56 | Q4G0X4 | |
| YVHRDLAARNILVNS | 736 | P54760 | |
| LLNDRGHIQLTYFSR | 936 | Q96S38 | |
| FLHALRELRLYQTDL | 116 | A6NIV6 | |
| QAGYERLQHAERRLS | 381 | Q13506 | |
| QNARAFRDLYSELRL | 136 | P35052 | |
| RNYIHLNLFASFILR | 176 | P43220 | |
| NRAEYVRLAINYRLH | 4626 | O95714 | |
| HYRSIININRRRYAA | 281 | Q5FYB0 | |
| YTRQREHLERNLATL | 1101 | Q96MR6 | |
| QRYFDHALTLRNTIL | 436 | Q658Y4 | |
| FRELALLFEHVQRAR | 376 | P56696 | |
| SYVHRDLAARNILVN | 741 | P54764 | |
| NYVHRDLAARNILVN | 741 | P29323 | |
| LNEASVLHNLRERYY | 116 | Q7Z406 | |
| TQLDLRRFRIYSNHS | 386 | P55058 | |
| RRFRIYSNHSALESL | 391 | P55058 | |
| LRLLSDRNHEDIFNY | 616 | Q9HCI6 | |
| IVAIDALHFRRYLDQ | 821 | Q86W56 | |
| RLLSFQRYFHASRLL | 71 | Q9NP56 | |
| HYDFGLRNILSVLRT | 2016 | Q96JB1 | |
| ALNHRQLVNIYFTRS | 651 | Q8IYU2 | |
| YIDRGRQLFRDNHLI | 596 | Q8IVU3 | |
| VLLRNAYREVSRAFH | 1111 | P55160 | |
| LRRLYLHNNSLRALE | 76 | Q50LG9 | |
| RLRHLNINAIRDYSF | 221 | Q96FE5 | |
| LAVRHLVYLRFLNLS | 281 | Q96FE5 | |
| SHFYRRQKALEAAVR | 461 | Q96KK3 | |
| QDSAIHLRVSRLYRQ | 221 | Q641Q3 | |
| YLRQLFRILFRTLNH | 276 | Q8N752 | |
| YRLSGVASNIQRLRH | 406 | A7KAX9 | |
| ATAQRLLQVYRQLRH | 861 | Q0VG06 | |
| VRLQRVTFLALHNYL | 271 | Q6ZV29 | |
| QNYIHRDLAARNILV | 306 | Q13882 | |
| RLYIQNLGRELRHTL | 361 | Q6P988 | |
| ELNLAYNRLASARVH | 386 | Q6PEZ8 | |
| YNRLASARVHHRAFR | 391 | Q6PEZ8 | |
| RHTLERYANRSLAIF | 36 | P0C7X3 | |
| RQRTLALLELFYDHS | 406 | A4FU69 | |
| NILHSFVQLRADYRS | 686 | O00471 | |
| RHQRLYSLLDRFRLS | 2051 | P42858 | |
| NYIHRDLRAANILVS | 376 | P08631 | |
| LRLLREARDFQAARY | 251 | Q9UJP4 | |
| YSLLRRAFLVEHNLV | 81 | Q9Y4C1 | |
| RYLAIVHAVFALRAR | 131 | P51677 | |
| LDLLRNNSRVERLYH | 161 | Q14152 | |
| RHDNAINYLDFLRAV | 1016 | Q5THR3 | |
| RYLAIVHAVFALRAR | 131 | P32246 | |
| HAQARLTLSYNRRGD | 486 | P09958 | |
| NLQAYRTFHVLLARL | 76 | P26441 | |
| RFRAQRLTELCYHLD | 446 | Q9H972 | |
| SYTQEAIHFQLLVRR | 66 | P09172 | |
| FLLRRGASVNSRNHY | 96 | Q68DC2 | |
| DNHVHSSFIYRRLRN | 31 | P22003 | |
| AILNRFRNYFRHIVN | 716 | Q0VDD8 | |
| LVTLAARAVRNNYRH | 396 | Q6ZNC8 | |
| RVRLVSHLNNYASQR | 151 | Q9Y5J3 | |
| TFVQRFRLQYLLGSH | 181 | A6NGE4 | |
| DRYNQFHIRRFEALL | 46 | Q9NWZ3 | |
| SLQHALAQSYQRRAR | 1711 | Q9BYK8 | |
| LAQSYQRRARSLHLA | 1716 | Q9BYK8 | |
| LQNLGLDRSLFERYH | 2401 | Q9BYK8 | |
| FSHYDRQLRNDILVI | 301 | A5D8W1 | |
| HYSFAARPRRLTQLA | 56 | Q9Y238 | |
| LDLQRFHSHTLRLYR | 1656 | P21817 | |
| RLLYQQARLHTRGAA | 3761 | P21817 | |
| FTRYLFVLQLRHDIL | 176 | Q9H329 | |
| VSQRADARYRHLIAL | 156 | O14654 | |
| RRQLYCRTGFHLQIL | 66 | Q9NP95 | |
| RSFRVDTAKLQHRYQ | 81 | Q8IWL3 | |
| RIRRAQLAHYNFQFV | 656 | Q9BW92 | |
| ADNYHLARRRTLQVV | 26 | Q7Z7C8 | |
| HLHNSYLDLQRRYGR | 476 | Q68CR1 | |
| RNIYNSFHKLRDRAE | 226 | Q9Y5X2 | |
| RLAYAIIQFLHDQLR | 6 | O43765 | |
| SVSFRRYNRSLHARI | 416 | O75159 | |
| DYAYTQALLLHQRAR | 511 | Q8N5C8 | |
| REAQRYFEHALTLRN | 76 | P0C866 | |
| RVFQHLGNLQVLRLY | 191 | Q8TF66 | |
| LRRYTSLNHLAQAAR | 511 | P48378 | |
| LRRYTSLNHLAQAAR | 496 | P48380 | |
| RNAGYAVSLRVQHRL | 86 | P57105 | |
| YRRNQIHLFGVLLAI | 41 | Q9H841 | |
| YLRQLFRILFRTLNH | 276 | P48729 | |
| FRHLRLQYIISDLAS | 331 | Q8NEA9 | |
| FLHLRRYSNLILNLF | 806 | Q8NEB9 | |
| NLLAFQHSERIYFRA | 231 | Q9NQV5 | |
| ILQEREYRLQARIAH | 366 | P51532 | |
| EYRLQARIAHRIQEL | 371 | P51532 | |
| FAYRLELNGHRRRLT | 221 | Q8IUQ4 | |
| FLLQRVHSLYRRTGA | 281 | O15127 | |
| DSRRLAAILNNAHYL | 2546 | Q9UKZ4 | |
| LAQHYLLEAVRLFSR | 921 | Q8TE82 | |
| SQRLADQYRRHSLFG | 991 | Q14191 | |
| FRRLQLFTHLRQDLE | 486 | Q6IE81 | |
| FYGRLVAVATLRNHR | 6 | Q9P2R7 | |
| AAAFRESLNRHRYLN | 41 | P43234 | |
| AILARYRANASREAL | 286 | Q9H2A9 | |
| RIAHQYFAQLSALQR | 386 | Q9H2A9 | |
| QVALQLAFYRLHRRL | 536 | P28329 | |
| ILRFLRARKFHQADA | 76 | Q8IUQ0 | |
| RARKFHQADAFRLLA | 81 | Q8IUQ0 | |
| LNEASVLHNLRERYF | 96 | P35749 | |
| QERRNSLLHGYRSLI | 361 | Q9HA65 | |
| DLAARNVLLVNRHYA | 461 | P43403 | |
| QLLYERFKRQQHALR | 701 | Q92574 | |
| RAQLRGQHFYAVERR | 311 | Q15654 | |
| FRYRSNLLEHQRLHL | 941 | P0CJ78 | |
| QQHLAFRDRRAYLFA | 241 | Q2NL82 | |
| ARLLARLQHDCVLYF | 1646 | Q15772 | |
| RFRYHFRGNRQTNVL | 316 | Q6NUQ1 | |
| YRSANFREHIQRRHR | 186 | Q9Y508 | |
| VLILAYFRRLHCTRN | 206 | Q03431 | |
| RLSRDQRFRESIYHI | 476 | A6NEE1 | |
| RHRSINLFLHGYQRF | 3501 | Q15413 | |
| AERHARLNDSYRLQR | 351 | Q13813 | |
| HLNNRLGDQRRVYSF | 281 | Q5T4T6 | |
| ARLENGRFVYRIHRS | 351 | Q99594 | |
| AALRRVLTAYAHRNP | 571 | O95759 | |
| AQRLRFRQFQYHVAS | 36 | Q8NBB4 | |
| AFRQSANLYVHRRIH | 301 | Q8TF20 | |
| AQISRRYSDFERLHR | 166 | Q969T3 | |
| RYSDFERLHRNLQRQ | 171 | Q969T3 | |
| DLAYTHRNLFRRLEE | 61 | Q9NRS6 | |
| QQYFSRTDRLLKHRR | 351 | Q9Y2X9 | |
| RVLVTLFDSRHLLYQ | 1241 | P21359 | |
| LRAHRLHQLAFDTYQ | 41 | P01241 | |
| HFVINQLRNRRYIIS | 96 | A6NKC9 | |
| RYREFAILHQNLKRE | 196 | Q96L92 | |
| RREALVQAHIYQLFL | 1191 | Q9H254 | |
| VQAHIYQLFLRDLRQ | 1196 | Q9H254 | |
| ELARIRAHRQLVFRY | 1631 | Q9NY15 | |
| YLRRAEEIFNCHLQR | 106 | Q9Y6S9 | |
| GRFLRHQYNAQLSRR | 271 | Q9BT92 | |
| LHHRRSRYQDILVFR | 41 | P19623 | |
| DAVSRYHRALLQLRG | 26 | Q8N5M4 | |
| RASLAIHRLNLALAY | 221 | Q6PF05 | |
| LQQLAYHTVNRRYRE | 571 | Q92543 | |
| ILRRDLNFHVFLEYN | 156 | Q9UNH7 | |
| AHERLQLLFYQRTFV | 971 | Q8IUG5 | |
| FVRATVHDYRLVLNR | 346 | P07949 | |
| VILSLFNHIYFRRTL | 556 | Q9HBG4 | |
| FNHIYFRRTLNIILQ | 561 | Q9HBG4 | |
| QELFRQLFRQLRYHE | 51 | P59923 | |
| TSQEIFRQRFRHLRY | 46 | Q9UNY5 | |
| SRFYEHRRSSVVLNL | 176 | Q6ZR37 | |
| GLRNAFLIQHENRYR | 626 | Q6ZR37 | |
| HLVYAVIRFLREQSQ | 6 | Q96EQ0 | |
| QRFLYLSTKRNHEQR | 1101 | Q8NAP3 | |
| KAFNRNSYLILHRRI | 496 | P17029 | |
| SALRRHYNRRLESQF | 301 | Q9Y4F4 | |
| SFTQNVHRLVNDLRY | 1096 | Q96QU8 | |
| HYNLARSSRPFERRL | 1011 | Q12789 | |
| RRLLQQAARAALHFF | 56 | P49788 | |
| AFRLASYLRQHRRVH | 306 | Q8NAF0 | |
| HQQRQASELRRLYRH | 46 | Q702N8 | |
| AFRQRTYLNQHRRIH | 681 | A8MQ14 | |
| ARIAFSAYLQHVQIR | 676 | Q6EMB2 | |
| QLSDSNFRRHILLQY | 311 | Q96FV9 | |
| LARRNADVFLKYLHR | 1076 | O75962 | |
| YRLNRQIRQHCLAFR | 926 | Q15386 | |
| RLRRNHSNAQFIESY | 311 | P41229 | |
| YLLRTSLHREREQAQ | 561 | Q9C099 | |
| ARASQLRHEGNRLYR | 241 | Q496Y0 | |
| RQILSDVAIRIYHQF | 1486 | Q9NQX4 | |
| LHQQYRLARQRIIQF | 806 | Q13402 |